Moreover, we identify the synthetic lethal interaction between ARH3 and PARG, which is caused by extreme levels of PARylation, and highlight ARH3 as a promising drug target and a biomarker for cancer cell sensitivity to PARP and PARG inhibition. This evidence concerns the gene PARG and cancer.